Agricultural Products and Services

Arcadia Biosciences

Arcadia Biosciences released FY2026 Q1 earnings on May 14 (EST), actual revenue USD 1.1 M (forecast USD 1.6 M), actual EPS USD -2.11 (forecast USD -0.8)

Arcadia Biosciences released FY2025 Q4 earnings on March 26 (EST), actual revenue USD 901K (forecast USD 1.4M), actual EPS USD -0.9776 (forecast USD -0.66)

Arcadia Biosciences released FY2025 earnings on March 26 (EST), actual revenue USD 4.858 M (forecast USD 5.955 M), actual EPS USD -1.7097 (forecast USD -2.56)

Arcadia Biosciences released FY2025 Q3 earnings on November 7 (EST), actual revenue USD 1.302 M (forecast USD 1.9 M), actual EPS USD 0.62 (forecast USD -0.54)

Arcadia Biosciences released FY2025 9 Months Earnings on November 7 (EST), actual revenue USD 3.957 M, actual EPS USD -0.741

Arcadia Biosciences released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.455 M (forecast USD 1.6 M), actual EPS USD -3.261 (forecast USD -0.79)

Arcadia Biosciences released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 2.655 M, actual EPS USD -1.3603

Arcadia Biosciences released FY2025 Q1 earnings on May 8 After-Market EST, actual revenue USD 1.2 M (forecast USD 1.3 M), actual EPS USD 1.9 (forecast USD -0.98)

Arcadia Biosciences Updates Business Combination Agreement with Roosevelt Resources

Arcadia Biosciences Reports Quarterly Earnings

Arcadia Biosciences to release FY2025 Q1 earnings on May 8 After-Market EST, forecast revenue USD 1.3 M, EPS USD -0.98

Halper Sadeh LLC Investigates Arcadia Biosciences for Securities Violations

Arcadia Biosciences Reaches Patent Transfer Agreement with Third Party

Arcadia Biosciences released FY2024 Q4 earnings on March 20 After-Market (EST), actual revenue 1.216 M USD (forecast 1.15 M USD), actual EPS -2.9773 USD (forecast -0.89 USD)

Arcadia Biosciences released FY2024 annual earnings on March 20 After-Market (EST), actual revenue 5.045 M USD (forecast 4.98 M USD), actual EPS -5.1624 USD (forecast -1.1 USD)

Akadia Biosciences Expects 2.6% Revenue Growth and $0.89 Loss per Share for 2024 Quarter

Arcadia Biosciences to Release FY2024 Q4 Earnings on March 20, 2025, After-Market EST; Forecasted Revenue: 1.15 M USD, EPS: -0.89 USD

Arcadia Biosciences and Roosevelt Resources Reach All-Stock Merger Agreement

Arcadia Biosciences released FY2024 9 Months Earnings on November 12 After-Market EST, actual revenue USD 3.83 M, actual EPS USD -2.1874

Arcadia Biosciences released FY2024 Q3 earnings on November 12 After-Market EST, actual revenue USD 1.537 M (forecast USD 1.4 M), actual EPS USD -1.1853 (forecast USD -0.81)

OPTIMI HEALTH CORP

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

HCW Biologics

Micware

GCL Global

Silexion Therapeutics

MetaVia

Vida Global

MicroAlgo

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

RKDA

Earnings Watch

Arcadia Biosciences | 10-Q: FY2026 Q1 Revenue: USD 1.1 M

Arcadia Biosciences | 8-K: FY2026 Q1 Revenue: USD 1.1 M

XXII

BYND

COST

In Friday's pre-market session, several consumer staples stocks saw significant movements. Gainers included 22nd Century Group (XXII) up 19.2% to $1.86, Arcadia Biosciences (RKDA) up 12.38% to $1.18, and Beyond Meat (BYND) up 11.78% to $1.1. Estee Lauder (EL) rose 8.85% to $83.5. Conversely, TDH Holdings (PETZ) fell 58.4% to $0.42, Sadot Group (SDOT) dropped 24.53% to $0.74, and Meiwu Technology (WNW) decreased 11.25% to $3.79. Other notable losers included Moolec Science (MLEC) and Reed's (REED).

benzinga_article

Meiwu Tech

22nd Century

Beyond Meat

Estee Lauder

Target

Costco Wholesale

Kroger

Caring Brands

IP Strategy

Sadot

Moolec Science SA

Reed's, Inc.

Wing Yip Food China

CARING BRANDS INC

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

REEDS INC

12 Consumer Staples Stocks Moving In Friday's Pre-Market Session

FTXG

The article discusses three oversold stocks in the consumer staples sector that may present buying opportunities due to their low Relative Strength Index (RSI) values. Clorox Co (CLX) has an RSI of 26.1 and reported flat revenue, while Arcadia Biosciences Inc (RKDA) has an RSI of 26.9 and saw a significant stock decline. Big Tree Cloud Holdings Ltd (DSY) has the lowest RSI at 21.2 and is transferring its listing to Nasdaq. These stocks may offer potential short-term performance as they are considered undervalued.

Big Tree Cloud

Clorox

SPDR FD Consumer Staples

ISHRS S&Pp Glb Cons Staple

First Trust NASDAQ Food & Beverage

VG Consumer Stap

BIG TREE CLOUD HOLDINGS LIMITED C/WTS 07/06/2029 (TO PUR COM)

Top 3 Risk Off Stocks That May Rocket Higher In May

Arcadia Biosciences | 8-K: FY2025 Q4 Revenue Misses Estimate at USD 901 K

Arcadis NV (ARCAY.PK) has secured two significant project wins in Los Angeles, totaling over $18 billion. The LA Convention Center Modernization and Expansion program, valued at $2.5 billion, aims to create over 15,000 jobs, while the Clean Water Program project involves a $7.5 million contract with the City of Los Angeles for various initiatives. Arcadis's stock is currently priced at $42.00 on the OTC Markets.

rttnews

Arcadis Bags Two Project Wins Worth Over $18 Bln In Los Angeles